Published in Adv Hematol on August 18, 2015
Gingival fibromatosis: clinical, molecular and therapeutic issues. Orphanet J Rare Dis (2016) 0.84
Primary rare anaplastic large cell lymphoma, ALK positive in small intestine: case report and review of the literature. Diagn Pathol (2016) 0.75
Retracted: Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions. Adv Hematol (2016) 0.75
Plasmablasticlike lymphoma arising within chronic pyoderma gangrenosum. JAAD Case Rep (2017) 0.75
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36
HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol (2008) 3.21
Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol (2004) 3.09
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. J Clin Oncol (2008) 2.80
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol (2004) 2.30
HIV-associated lymphomas and gamma-herpesviruses. Blood (2008) 2.27
Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review. Leuk Res (2011) 2.10
Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics. Am J Clin Pathol (2010) 2.10
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood (2006) 2.09
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol (2004) 1.97
Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol (2005) 1.66
IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol (2010) 1.64
Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol (2005) 1.61
Plasmablastic lymphoma: a clinicopathologic correlation. Ann Diagn Pathol (2006) 1.54
Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma (2010) 1.51
Hematopoietic cell transplantation for plasmablastic lymphoma: a review. Biol Blood Marrow Transplant (2014) 1.50
The biology and treatment of plasmablastic lymphoma. Blood (2015) 1.44
Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica (2010) 1.42
How I treat HIV-associated lymphoma. Blood (2012) 1.42
Plasmablastic lymphoma: a systematic review. ScientificWorldJournal (2011) 1.42
Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology (2003) 1.41
Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer (2003) 1.41
Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med (2001) 1.34
Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer (2012) 1.31
Plasmablastic lymphoma: a review. Oral Dis (2008) 1.31
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma. Oncologist (2010) 1.31
KSHV/HHV8-associated lymphomas. Br J Haematol (2007) 1.29
Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol (2003) 1.27
HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk (2011) 1.22
Paraproteinemia, plasmacytoma, myeloma and HIV infection. Leukemia (1997) 1.19
Bortezomib in plasmablastic lymphoma: a case report and review of the literature. Onkologie (2013) 1.14
Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma (2004) 1.13
Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma (2002) 1.12
Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone. J Clin Oncol (2010) 1.12
Prospects and limitations of T cell receptor gene therapy. Curr Gene Ther (2011) 1.11
HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol (2004) 1.09
Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol (2014) 1.09
Diagnosis and management of lymphomas and other cancers in HIV-infected patients. Nat Rev Clin Oncol (2014) 1.08
Minimum diagnostic criteria for plasmablastic lymphoma of oral/sinonasal region encountered in a tertiary cancer hospital of a developing country. J Oral Pathol Med (2008) 1.07
Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 1.05
AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib. Eur J Haematol (2009) 1.01
Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: a case report and review of literature. Int J Oral Maxillofac Surg (2009) 1.00
Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol (2005) 0.97
Human immunodeficiency virus-negative plasmablastic lymphoma in Korea. Leuk Lymphoma (2009) 0.96
Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: a case report. J Oral Maxillofac Surg (2007) 0.96
Cutaneous presentation of plasmablastic post-transplant lymphoproliferative disorder in a 14-month-old. Pediatr Dermatol (2010) 0.95
Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma. J Hematol Oncol (2009) 0.95
Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma. Clin Lymphoma Myeloma Leuk (2010) 0.95
Plasmablastic lymphoma in an immunocompetent patient. J Clin Oncol (2009) 0.95
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma. Br J Haematol (2015) 0.94
Bortezomib-contained chemotherapy and thalidomide combined with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review. Clin Lymphoma Myeloma Leuk (2014) 0.94
Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature. Am J Clin Pathol (2009) 0.94
Plasmablastic lymphoma arising at a cutaneous site. Histopathology (2005) 0.94
Current knowledge on HIV-associated Plasmablastic Lymphoma. Mediterr J Hematol Infect Dis (2014) 0.92
Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol (2007) 0.91
Epstein-Barr virus and human immunodeficiency virus-negative oral plasmablastic lymphoma. J Oral Pathol Med (2006) 0.91
Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ann Hematol (2008) 0.91
Primary central nervous system plasmablastic lymphoma in AIDS. Neuropathol Appl Neurobiol (2007) 0.91
EBV and HIV-Related Lymphoma. Mediterr J Hematol Infect Dis (2009) 0.91
Plasmablastic lymphoma: one or more entities? Am J Hematol (2008) 0.90
Vulvar plasmablastic lymphoma in a HIV-positive child: a novel extraoral localisation. J Clin Pathol (2009) 0.89
Plasmablastic lymphoma: are more intensive regimens needed? Leuk Res (2011) 0.88
Plasmablastic lymphoma of the maxillary sinus in an HIV-negative patient: a case report and literature review. Springerplus (2013) 0.88
Plasmablastic lymphoma of oral cavity in a HIV-negative child. Pediatr Blood Cancer (2010) 0.87
Plasma cell myeloma in patients who are HIV-positive. Am J Clin Pathol (1994) 0.87
Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusion. Histopathology (2005) 0.87
Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen. Hematology Am Soc Hematol Educ Program (2012) 0.86
Plasmablastic lymphoma of head and neck: report of two new cases and correlation with c-myc and IgVH gene mutation status. Head Neck Pathol (2007) 0.86
Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma. Br J Dermatol (2005) 0.85
Epstein-Barr virus-related plasmablastic lymphomas arising from long-standing sacrococcygeal cysts in immunosuppressed patients. AIDS (2003) 0.85
Plasmablastic lymphoma of the oral cavity in an HIV-positive child. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.83
Plasmablastic lymphoma of the oral cavity: a review. Oral Oncol (2010) 0.83
Absence of immunohistochemical evidence for human herpesvirus 8 (HHV8) in oral cavity plasmablastic lymphoma in an HIV-positive man. Clin Oncol (R Coll Radiol) (2000) 0.83
Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib. Hematol Oncol (2012) 0.83
Multifocal cutaneous and systemic plasmablastic lymphoma in an infant with combined living donor small bowel and liver transplant. Pediatr Transplant (2009) 0.82
[Plasmablastic lymphoma in a patient with HIV infection: an unusual case located in the skin]. Ann Pathol (2005) 0.82
Presence of p16 hypermethylation and Epstein-Barr virus infection in transplant-associated hematolymphoid neoplasm of the skin. J Am Acad Dermatol (2006) 0.82
Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas. Oral Oncol (2011) 0.81
Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer (2010) 0.81
Chimeric antigen receptor modified T cell therapy for B cell malignancies. Int J Hematol (2013) 0.80
Long-term survivor of human immunodeficiency virus-associated plasmablastic lymphoma. Indian J Med Paediatr Oncol (2013) 0.80
CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab. Eur J Haematol (2014) 0.80
Plasmablastic lymphoma in pediatric patients: clinicopathologic study of three cases. Ann Diagn Pathol (2012) 0.80
Brentuximab vedotin demonstrates activity in a patient with plasmablastic lymphoma arising from a background of chronic lymphocytic leukemia. J Clin Oncol (2013) 0.80
Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia. Diagn Pathol (2015) 0.79
A case of oral plasmablastic lymphoma and review of current trends in oral manifestations associated with human immunodeficiency virus infection. J Oral Maxillofac Surg (2014) 0.78
Pediatric plasmablastic lymphoma: a clinicopathologic study. Int J Surg Pathol (2014) 0.78
Autologous hematopoietic stem cell transplantation for plasmablastic lymphoma: the European Society for Blood and Marrow Transplantation experience. Biol Blood Marrow Transplant (2015) 0.77